Developing an Evidence Base for the Use of Art Psychotherapy Within a Perinatal Mental Health Service

July 19, 2022 updated by: Amy Stanhope, University of Derby

Primary Outcomes:

  • To measure the impact of art therapy within this specific perinatal client group
  • Attempt to establish a quality evidence base for the intervention within this setting

Secondary Outcomes:

  • Capture the participants lived experience of Art Therapy
  • Measure participant interaction with art materials during Art Therapy intervention
  • Measure any changes in mental wellbeing of the participants during Art Therapy intervention
  • Monitor patient reported quality of life during Art Therapy intervention
  • Record changes in mother-infant interaction during Art Therapy intervention

Hypotheses:

  • The measures will show an improvement in mental wellbeing, quality of life and mother-infant interaction in participants who receive the Art Therapy intervention compared to the baseline measurements taken at the start of the intervention.
  • The wait-list control group who have not yet received the intervention will display lower scores on the above measures, prior to receiving the Art Therapy intervention.

The aim of this study is to measure the impact of art therapy within this specific perinatal client group in order to attempt to establish an evidence base for the intervention within this setting; while following a primarily quantitative approach with complimentary qualitative elements. Art Therapy is a form of psychotherapy, based upon the premise of utilising art materials as a form of expression and communication; the roots of the theoretical approach lie in a psychodynamic approach to working with the unconscious.

Study Overview

Detailed Description

Methodology:

I intend to use a wait-list control group, whereby following admission to the unit a patient will follow the recruitment process detailed below, only after the recruitment process has been completed in full would consenting patients be randomised to an intervention group which will begin Art Therapy sessions in due course, or to a wait-list control group for a minimum of two weeks and a maximum of six weeks. The intervention group members will receive the Art Therapy intervention, while the waitlist control group are fully aware of the research and are waiting to receive it at a later date. The waitlist participants will be made fully aware that if they are discharged before therapy has become available to them, or if they reach the maximum term of 6 weeks on the waiting list, then they may not receive the intervention. Participants who reach the maximum term of 6 weeks on the waiting list while waiting for therapy availability will be withdrawn from the research and offered a debrief meeting in order to answer any remaining questions about the research. This maximum six week term is based upon the six week average duration of patient stay within the unit.

I am a qualified Art Psychotherapist and will be using a non-directive approach in order that the clients will lead their interactions with the art materials and with the therapy process.

Art Therapists are governed by the British Association of Art Therapists and the Health and Care Professions council who each set standards of professional therapy delivery. I will establish and facilitate a safe therapeutic provision of weekly individual Art Therapy sessions for patients of the unit.

I will work closely with the unit staff team in order to introduce and create a shared understanding about the therapeutic intentions of the art therapy provision. The additional benefit of employing a non-directive, client centred approach to Art Therapy sessions is that this will ensure that the clients themselves have key influence over the theme and artistic content of therapy sessions. The client presentation will then be analysed using a series of recognised quantitative scales to monitor client progress, therefore minimising the influence of the multiple therapists on the research data and increasing the quality of the data.

There will be an initial assessment period within the intervention. This will consist of one session of 50 minute duration, during which an assessment will be made about the clients interaction with art materials. This will be conducted by utilising the Hyland Moon approach of categorising art materials as high or low structure based on their properties. High structure materials being easy to control versus low structure materials being more fluid in nature and therefore more challenging to work with. The differing art making experiences and client interactions that these varying art materials can produce will be valuable in gaining an insight into the clients functioning, in order to facilitate an assessment of the appropriateness of the intervention within the context of each individuals presentation and diagnoses. Following assessment, both the client and the therapist will have the opportunity to either withdraw or consent to continuation of the intervention. Should the therapist determine following assessment that Art Therapy is not appropriate for the patient, for example in the instance that the patients presentation is so severe that an offering of Art Therapy may pose a risk to the therapist or the patient, or that the level of willingness to engage in the assessment phase (in spite of consent previously given) is so lacking that a continued offering is not sustainable, then the patient will be withdrawn from the research. In this instance, a letter will be provided to the patient, inviting them to return for a re-assessment for Art Therapy sessions, at such point as they feel ready to do so in future after a minimum period of two weeks have elapsed since prior assessment. The length of each clients engagement with the Art Therapy sessions, i.e. number of sessions provided, will vary due to the nature of the population. However, the average stay for a client within the unit is 42 days and they would be eligible for inclusion in the research from the point of admission, subject to consent and recruitment procedures. The intention will be to offer a series of five sessions of therapy following assessment. Should the patient be discharged prior to the end of therapy, the option will be offered of returning to the unit for the remaining sessions as an outpatient. The use of qualitative and quantitative data collection methods will account for capturing the complexity of the intervention. The provision of this intervention within the unit is over and above what the unit's "care as usual" plan is, because an Art therapy service does not currently exist in the setting. The following measurement scales are already in use as standard practice within the perinatal unit, therefore staff are comfortable with their application and credibility within the NHS setting. In order to honour the multidisciplinary approach to working with the patients, I therefore intend to have continuity in measures and will employ all of these scales at intervals throughout the participants engagement in therapy sessions.

Quantitative measures:

The use of quantitative measures within the research will mitigate against bias and the influencer of the researcher on the research findings, by presenting statistical data which will then be analysed using IBM SPSS Statistics software and reviewed by my supervisors. In addition to this, an element of influence will be eliminated via the fact that student therapists will also be delivering the intervention.

Application of scales:

The weekly questionnaires (ReQol10 and Bethlem Mother-Infant Interaction Scale) will be administered by the unit care team as part of their standard care plan, the researcher has requested permission from the patient (within the patient consent form) to access the patients medical records to withdraw the weekly scores from these questionnaires, for anonymous inclusion within the research data. This will avoid patients being asked to complete weekly duplicates of these questionnaires that they will already be completing with the unit care team. The researcher and therapists will already be authorised to have access to patient medical records under the terms of the honorary contract as provided by the unit, in order to record brief therapy notes.

Statistical Analysis:

Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using Repeated Measures One-Way ANOVA to analyse the data collected from weekly questionnaires, alongside t-test and One-Way ANOVA analyses which will be applied to the questionnaires used during the assessment phase and at the end of therapy engagement.

Please see the Participant Timeline diagram and Table of Measures attached for additional clarity regarding administration of measures.

Qualitative measure:

In addition to this, I intend to employ the qualitative measure of an end of therapy Reflect Interview which will be recreated with each consenting participant, using the same set of semi-structured interview questions as written by the researcher and AIR (Audio Image Recording - as developed by N. Springham) piece as a way of commemorating and bringing an end point to the work done during Art Therapy sessions. As this is a qualitative measure and has been tested for feasibility as such, the interview questions are semi-structured in order to allow for the client to fully express their lived experience of therapy. I will undertake collaborative editing with client of the AIR recording, in order to demonstrate that I am working to reduce the bias / outside influence on the final piece, this will be achieved by giving the client an opportunity to state at the end of the interview whether they wish me to remove any sections of audio or add anything in. Data will be collected from the AIR's via transcription and analysis (by the researcher) of the transcripts for recurring words and themes within each patients interview.

In spite of the cohort being relatively small and the research undertaken over a relatively short timescale, a large amount of pre and post intervention data may be produced. This will require statistical analysis in order to attempt to determine statistically significant change in the clients presentation. I intend to code all qualitative data gathered using a 6-step framework of thematic analysis devised by Braun & Clarke, during which I will code interview transcripts and then identify both semantic and latent themes within the coding. Due to the volume of qualitative data in the form of AIR transcripts that I anticipate being generated during the research, I intend to use professional and encrypted Nvivo software, provided by the University to aid the data analysis process.

The end of trial date will be signified by the completion of the minimum term of one full year of data collection.

In order that the population of participants are randomly, yet evenly allocated into wait-list and treatment groups, a blocked randomisation process will be applied. This will be conducted via Sealed Envelope, a website facility which can be customised to produce a list of participants and their randomly allocated group. In addition, the website will allocate each participant with a randomly generated code consisting of two letters and one number, it is ensured that no participant code within the list can ever be repeated. Participant codes will be used in place of names on all questionnaires, the AIR audio file and all data records in order to preserve anonymity. The allocation concealment mechanism within the randomisation process will be that the randomisation list will be produced and held by the Director of Studies and Supervisor, Jamie Bird.

Each time a participant has completed the introduction and recruitment process and given their consent to be involved in the research, the clinician-researcher will then obtain from the Director of Studies the next available participant code for that individual and establish whether they will be allocated to the wait-list or treatment group. Throughout the study, all participants shall remain anonymous to the Director of Studies and shall not be given any identifying information about participants. A record of participant names and the randomisation log of codes will be recorded in the site file which will be stored in an encrypted electronic format and will only be accessed by the lead clinician-researcher. In addition to this, including the varying size blocked element within the randomisation process adds another layer of allocation concealment as the clinician-researcher will be unable to predict the next allocation outcome. The benefit of this would be that the participants would be randomised and their clinical presentation could be measured in comparison as a control group to isolate the effect of the Art Therapy intervention as the independent variable. Additionally, this approach is considered to be ethically preferable to a control group which denies participants access to an intervention for the entirety of a research study.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Derbyshire
      • Derby, Derbyshire, United Kingdom, DE22 3WQ
        • The Beeches, Royal Derby Hospital Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Individuals admitted to the perinatal Mother and Baby unit who are able to speak English and who consent to take part.

Exclusion Criteria:

  • Individuals who do not speak English.
  • Individuals who do not consent to take part.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intervention Group
Receives Art Therapy assessment and intervention
Art Therapy is a form of psychotherapy, based upon the premise of utilising art materials as a form of expression and communication; the roots of the theoretical approach lie in a psychodynamic approach to working with the unconscious.
Active Comparator: Wait List Control Group
Added to wait list to receive intervention at a later date, participant is made aware of this
Wait list control group. Participants randomised to Wait List group or Intervention group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure any changes in mental wellbeing during the term of the Art Therapy intervention.
Time Frame: Duration of therapeutic intervention within unit - approximately one year.
Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), 14 items - sensitive to changes in mental wellbeing at the individual level. This scale will be used once during the one week assessment and once at the end of the five week therapy engagement. The total score is obtained by summing the score for each of the 14 items. The scoring range for each item is from 1 - 5 and the total score is from 14-70. A score of 40 and below corresponded to probable depression and a score of 44 and below to possible depression.
Duration of therapeutic intervention within unit - approximately one year.
Monitor patient reported quality of life during the term of the Art Therapy intervention.
Time Frame: Duration of therapeutic intervention within unit - approximately one year.

ReQol20 (Recovering Quality of Life) - Patient reported outcome measure. To assess the quality of life for people with varying mental health conditions. Used once during the one week assessment period and once at the end of the five week therapy engagement.

A ReQoL20 score between 0 and 49 is considered as falling within the clinical range. A score of 50 and above is considered as falling within the range of the general population.

Duration of therapeutic intervention within unit - approximately one year.
Monitor patient reported quality of life during the term of the Art Therapy intervention and during the wait-list period.
Time Frame: Duration of therapeutic intervention within unit - approximately one year.
ReQol10 (Recovering Quality of Life) - Patient reported outcome measure. To assess the quality of life for people with varying mental health conditions. Used once during the one week assessment period and once at the end of the five week therapy engagement. The ReQol10 scale which includes 10 questions, used weekly for the duration of the engagement in therapy and during the wait-list period. A ReQoL-10 score between 0 and 24 is considered as falling within the clinical range. A score of 25 and above is considered as falling within the range of the general population
Duration of therapeutic intervention within unit - approximately one year.
Monitor changes in mother-infant interaction during the term of the Art Therapy intervention and during the wait-list period.
Time Frame: Duration of therapeutic intervention within unit - approximately one year.
Bethlem Mother-Infant Interaction Scale - Assesses disturbances of mother-infant interaction. This scale will be used weekly for the duration of the engagement in therapy (maximum five week duration available) and during the wait-list period (a minimum duration of two weeks and maximum of six weeks). 7-item, 5-point rating scale used to measure mother-infant adjustment. Scoring is rated from 0 to 4, with 0 indicating the mother is judged to be interacting with her baby in an appropriate, sensitive and well- organised manner. A rating of 4 indicates that the mother and infant have been nursed separately for the majority of the week.
Duration of therapeutic intervention within unit - approximately one year.
Statistical analysis of change in mental wellbeing as assessed by the use of Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
Time Frame: End of therapy intervention - after approximately one year of therapy work in unit.
Statistical analysis conducted by the researcher, via IBM SPSS Statistics software, using Repeated Measures One-Way ANOVA and t-test to analyse the data collected from questionnaire used during the assessment phase and at the end of therapy engagement.
End of therapy intervention - after approximately one year of therapy work in unit.
Statistical analysis of change in patient reported quality of life as assessed by the use of ReQol20 (Recovering Quality of Life)
Time Frame: End of therapy intervention - after approximately one year of therapy work in unit.
Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using t-test and One-Way ANOVA analyses which will be applied to the questionnaires used during the assessment phase and at the end of therapy engagement.
End of therapy intervention - after approximately one year of therapy work in unit.
Statistical analysis of change in patient reported quality of life as assessed by the use of ReQol10 (Recovering Quality of Life)
Time Frame: End of therapy intervention - after approximately one year of therapy work in unit.
Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using t-test and One-Way ANOVA analyses which will be applied to the questionnaires used weekly during the wait list and therapy intervention.
End of therapy intervention - after approximately one year of therapy work in unit.
Statistical analysis of changes in mother-infant interaction as assessed by the use of the Bethlem Mother-Infant Interaction Scale.
Time Frame: End of therapy intervention - after approximately one year of therapy work in unit.
Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using t-test and One-Way ANOVA analyses which will be applied to the questionnaires used weekly during the wait list and therapy intervention.
End of therapy intervention - after approximately one year of therapy work in unit.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Capture the participants lived experience of Art Therapy
Time Frame: End of therapy intervention with each client, approximately 6 weeks
Qualitative measure of a participant, therapist interview combined with discussion of the participants selected artwork. Semi-structured interview in line with the AIR (Audio Image Recording) approach as established by Neil Springham. This will provide descriptive based, qualitative outcome data which will be analysed for recurring themes in order to capture the participants experience. Themes such as discussion of improved wellbeing are anticipated.
End of therapy intervention with each client, approximately 6 weeks
Measure participant interaction with art materials during Art Therapy intervention
Time Frame: Assessment phase only, first week of therapy, one week
During the assessment sessions, client presentation and artwork produced will be analysed using the qualitative approach of categorising art materials and observations of the clients interactions with the materials. This will be conducted by utilising the Hyland Moon approach of categorising art materials as high or low structure based on their properties. High structure materials being easy to control versus low structure materials being more fluid in nature and therefore more challenging to work with. The differing art making experiences and client interactions that these varying art materials can produce will be valuable in gaining an insight into the clients functioning, in order to facilitate an assessment of the appropriateness of the intervention within the context of each individuals presentation and diagnoses.
Assessment phase only, first week of therapy, one week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jamie Bird, University of Derby

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 26, 2021

Primary Completion (Actual)

May 26, 2022

Study Completion (Actual)

May 26, 2022

Study Registration Dates

First Submitted

September 17, 2019

First Submitted That Met QC Criteria

September 26, 2019

First Posted (Actual)

September 27, 2019

Study Record Updates

Last Update Posted (Actual)

July 22, 2022

Last Update Submitted That Met QC Criteria

July 19, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perinatal Mental Health

Clinical Trials on Art Psychotherapy, Art Therapy

3
Subscribe